World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
66
Citations
13080
World Ranking
2439
National Ranking
988

Jeffrey S. Glenn publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jeffrey S. Glenn sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 200 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Jeffrey S. Glenn D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey S. Glenn sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 66 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Jeffrey S. Glenn is affiliated with Stanford University in the United States and has a research focus primarily in the field of Medicine. Their work spans several subfields including Epidemiology, Infectious Diseases, Hepatology, Molecular Biology, and Immunology.

The scientist's research covers a number of main topics, notably:

  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • RNA and protein synthesis mechanisms
  • Bacteriophages and microbial interactions

A selection of recent papers authored or co-authored by this researcher includes:

  • A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (2020), published in Nature
  • Progenitor identification and SARS-CoV-2 infection in human distal lung organoids (2020), published in Nature
  • Structure of the neurotensin receptor 1 in complex with β-arrestin 1 (2020), published in Nature
  • Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity (2020), published in Nature Cancer
  • RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look (2020), published in RNA

Frequent collaborators in their research include:

  • Ingrid Choong
  • Ralph S. Baric
  • Ohad Etzion
  • Colin Hislop
  • Saeed Hamid

The venues where Jeffrey S. Glenn has most frequently published are:

  • Journal of Hepatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • Hepatology
  • UNC Libraries

Best Publications

  • A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.

    Kenneth H. Dinnon;Sarah R. Leist;Alexandra Schäfer;Caitlin E. Edwards

  • Identification of a prenylation site in delta virus large antigen

    Jeffrey S. Glenn;John A. Watson;Christopher M. Havel;Judith M. White

  • Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

    Christoph Thomas;Ignacio Moraga;Doron Levin;Peter O. Krutzik

  • Structure of the neurotensin receptor 1 in complex with β-arrestin 1.

    Weijiao Huang;Matthieu Masureel;Qianhui Qu;John Janetzko

  • Progenitor identification and SARS-CoV-2 infection in human distal lung organoids.

    Ameen A. Salahudeen;Ameen A. Salahudeen;Shannon S. Choi;Arjun Rustagi;Junjie Zhu

  • Extracellular cGAMP is a cancer cell-produced immunotransmitter involved in radiation-induced anti-cancer immunity.

    Jacqueline A. Carozza;Volker Böhnert;Khanh C. Nguyen;Gemini Skariah

  • Six RNA Viruses and Forty-One Hosts: Viral Small RNAs and Modulation of Small RNA Repertoires in Vertebrate and Invertebrate Systems

    Poornima Parameswaran;Ella Sklan;Courtney Wilkins;Trever Burgon

  • Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis

    Shirit Einav;Doron Gerber;Paul D Bryson;Ella H Sklan

  • Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.

    Christopher Koh;Laetitia Canini;Laetitia Canini;Harel Dahari;Harel Dahari;Xiongce Zhao

  • RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look.

    Ramya Rangan;Ivan N. Zheludev;Rachel J. Hagey;Edward A. Pham

  • An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication

    Menashe Elazar;Ping Liu;Ping Liu;Charles M. Rice;Jeffrey S. Glenn;Jeffrey S. Glenn

  • In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

    Bruno B. Bordier;Junko Ohkanda;Ping Liu;Ping Liu;So Young Lee

  • Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication

    Menashe Elazar;Kwang Ho Cheong;Kwang Ho Cheong;Ping Liu;Harry B. Greenberg;Harry B. Greenberg

  • Early Treatment with Pegylated Interferon Lambda for Covid-19

    Unknown

  • Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.

    Jordan J Feld;Jordan J Feld;Christopher Kandel;Mia J Biondi;Mia J Biondi;Robert A Kozak

  • COVID-19 and emerging viral infections: The case for interferon lambda.

    Ludmila Prokunina-Olsson;Noémie Alphonse;Noémie Alphonse;Ruth E. Dickenson;Joan E. Durbin

  • Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses

    Kazuo Ohashi;Patricia L. Marion;Hiroyuki Nakai;Leonard Meuse

  • Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.

    Donghee Kim;Andrew A. Li;Chiranjeevi Gadiparthi;Muhammad Ali Khan

  • A Nucleotide Binding Motif in Hepatitis C Virus (HCV) NS4B Mediates HCV RNA Replication

    Shirit Einav;Menashe Elazar;Tsafi Danieli;Jeffrey S. Glenn;Jeffrey S. Glenn

  • Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States

    Donghee Kim;Andrew A. Li;Brandon J. Perumpail;Chiranjeevi Gadiparthi

  • Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification

    Richard M Deans;David W Morgens;Ayşe Ökesli;Sirika Pillay

Frequent Co-Authors

Nam-Joon Cho
Nam-Joon Cho Nanyang Technological University
Theo Heller
Theo Heller National Institutes of Health
Curtis W. Frank
Curtis W. Frank Stanford University
Mark A. Winters
Mark A. Winters Stanford University
Charles M. Rice
Charles M. Rice Rockefeller University
Harry B. Greenberg
Harry B. Greenberg Stanford University
Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Robert G. Gish
Robert G. Gish University of Nevada Reno
David E. Kleiner
David E. Kleiner National Institutes of Health
Mark A. Kay
Mark A. Kay Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens doors to diverse career pathways, some of which intersect with health information and medical coding fields. For individuals interested in the administrative and data-focused side of healthcare, pursuing a certified professional coder (cpc) credential can lead to rewarding roles that support clinical documentation and billing accuracy.

Those looking to expand their scope might consider obtaining a health information management bachelor degree salary, which reflects the growing demand and competitive wages in this sector. This degree equips graduates to manage healthcare data, improving patient care and regulatory compliance.

For flexibility and quality assurance, exploring an online cahiim accredited health information management degree can be an ideal option. These accredited programs ensure that students receive comprehensive training recognized by industry standards.

Additionally, accelerated pathways such as a medical billing and coding certificate online accelerated program offer a quick entry into the workforce, perfect for those seeking to complement their microbiology expertise with valuable technical skills in healthcare administration.

Best Scientists Citing Jeffrey S. Glenn

Trending Scientists

Recently Published Articles